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River Delta, Tanzania: declining transmission over
25 years revealed by different parasitological
metrics
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Salome Jesaja2, Johanna Sandlund1, Kazuyuki Tanabe3ˆ, Ulf Hammar4, Matteo Bottai4, Zulfiqarali G Premji5,6,
Anders Björkman7 and Ingegerd Rooth1,2
Abstract
Background: Assessments of the epidemiology of malaria over time are needed to understand changes in
transmission and guide control and elimination strategies.
Methods: A longitudinal population study was established in 1985 in Nyamisati village in the Rufiji River Delta,
Tanzania. A physician and research team lived in the village 1984–2000. Parasite prevalence by microscopy and two
PCR methods, spleen rates and haemoglobin levels were measured in repeated cross-sectional surveys between
1985 and 2010. Passive surveillance of malaria cases was maintained until end 1999. Bed nets were distributed after
the surveys 1993, 1999 and 2010.
Results: In 1985, overall parasite prevalence by microscopy was 70% (90% in children ages two to nine years). The
prevalence decreased gradually by microscopy (38.9% 1994, 26.7% 1999) and msp2-PCR (58.7% 1994, 44.8% 1999),
whereas real-time PCR prevalence remained higher throughout the 1990s (69.4% 1994, 64.8% 1999). In 2010, parasite
prevalence was 17.8% by real-time PCR and 16.3% by msp2-PCR, and estimated to 4.8% by microscopy. Spleen rates in
children ages two to nine years decreased earlier than parasite prevalence, from >75 to 42% in the 1980s, to nil during
the 1990s. The prevalence of severe and moderate anaemia decreased from 41.1 to 13.1%. No deaths at the time of
acute malaria were recorded when the research team lived in the village.
Conclusions: A marked decline in malaria transmission was observed over 25 years. The decrease was detected
after the arrival of the research team and continued gradually both before and after distribution of bed nets.
Spleen rates and microscopy identified early changes when transmission was still intense, whereas real-time PCR
was a more sensitive metric when transmission was reduced. The study provides historical data on malaria within
a closely monitored rural village and contributes to the understanding of changing epidemiology in sub-Saharan
Africa.
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Background
Malaria remains a major global health problem. The in-
fection is spread in tropical and subtropical regions with
the most intense transmission in sub-Saharan Africa.
Several countries have reported reduced transmission
over the last decade [1]. Understanding the temporal
changes in malaria transmission, determining factors
that have contributed to these changes, and identifying
optimal monitoring tools are important in designing fu-
ture control interventions [2].
The Nyamisati Malaria Research Project was set up in
1985 in a fishing village in Rufiji District, Tanzania. A
medical team established a health clinic in this commu-
nity, which previously lacked primary health care, and be-
came interested in understanding the impact of malaria. A
research project, in which all villagers were invited, aimed
to describe the epidemiology and clinical aspects of mal-
aria longitudinally. The first cross-sectional surveys in
1985–1988 revealed a holo-endemic setting with 90%
parasite prevalence and >75% spleen rates in two to nine
years old children [3]. Repeated cross-sectional surveys
were performed and a passive surveillance system for mal-
aria was maintained until year 2000 when the team
moved. Studies conducted within the project have de-
scribed various aspects of malaria, e.g., epidemiology
(1985–1988) and clinical presentation [3-5]; impact of co-
infections with measles, influenza and pertussis [6]; mo-
lecular epidemiology and dynamics of Plasmodium falcip-
arum populations [7-10]; parasite genetics and evolution
[11,12]; as well as immunology [13-16], and human im-
munogenetics [17,18]. Reports of decreasing transmission
in other African settings [19-21] inspired the research
team to return to the village in 2010 to perform a cross-
sectional survey to assess parasite prevalence.
This paper summarizes the epidemiology of malaria in
Nyamisati village over 25 years. Long-term changes in P.
falciparum prevalence were evaluated using microscopy
and two PCR methods: species-specific real-time PCR and
merozoite surface protein-2 (msp2) genotyping PCR.
Moreover, spleen rates, haemoglobin levels and incidence
of febrile malaria were assessed over time. The study
shows a marked yet gradual decline in malaria transmis-
sion in Nyamisati, and demonstrates that different
methods to monitor malaria endemicity are informative at
different stages of changing transmission intensity.
Methods
Study area and population
Nyamisati village (7°47′S; 39°16′E) is situated in the Rufiji
River Delta, the largest area of mangrove forest on the East
African coast, in the Pwani region, Tanzania (Figure 1). The
population is of Bantu origin and Muslim faith. Fishing and
rice farming are the main occupations. Houses are mainly
built in mud with roofs of grass and palm leaves. Malaria
transmission is perennial with some seasonal fluctuations
following the long and short rains, usually occurring in
March-June and November-January, respectively (Additional
file 1). HIV prevalence was 4.6% in adults in 1993. Sickle cell
trait was detected by electrophoresis in 15% of villagers [3].
Health care
A team, including a physician, a nurse and two locally
trained assistants lived in the village 1984–2000. A
health clinic was continuously available for consultations
free of charge. Except for a few traditional healers, there
were no other health facilities in this or neighbouring
villages at the time. The health care management was
gradually handed over to a governmental rural medical
aid (RMA). Emergencies and more complicated medical
conditions were treated by the physician or referred to
Mchukwi Hospital, 72 km away.
Malaria was diagnosed by microscopy and treated with
chloroquine during the first years and later on with
sulphadoxine-pyrimethamine (SP), alone or in combin-
ation with oral quinine. The different anti-malarial drugs
administered at the health unit are summarized in
Additional file 2. Artemether-lumefantrine (Coartem®)
was, according to the RMA, available in the village from
2009. Drugs were administered free of charge through
Figure 1 Location of Nyamisati village, Tanzania A) Location of
Nyamisati within the Rufiji District, Tanzania; B) Google Earth
map showing Nyamisati in the Rufiji River Delta.
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the health unit. There were no other drug outlets in the
village before 2000.
Malaria control
In 1985, 3% of households owned a bed net. Between
October 1993 and April 1994, 300 insecticide-treated
bed nets (ITNs) were distributed to pregnant women
and families with small children. The research team also
distributed bed nets after the cross-sectional surveys in
1999 (900 ITNs not re-impregnated) and 2010 (1,000
long-lasting insecticide-treated nets (LLINs). The bed
net coverage, assuming 1.8 individuals per net [22] was
4% in 1985, 45% in 1993–1994 and 100% after the sur-
vey in 1999. According to the villagers there was no
other large-scale distribution of bed nets between 1999
and 2010. Indoor residual spraying and larval control
were not used. Chemoprophylaxis with chloroquine and
later intermittent preventive treatment (IPT) with SP
were administered to pregnant women from a govern-
mental maternal health unit. Except for a small study in
1986 [5], chemoprophylaxis and IPT were not adminis-
tered to children.
Malaria surveillance and cross-sectional surveys
A passive surveillance system for malaria was main-
tained between 1986–1989 and 1993–1999. The villagers
were instructed to come to the clinic in the event of
fever. Individuals who presented with fever (axillary
temperature >37.5°C), or history of fever (“hot body”)
within 24 hours, and had parasites detected by micros-
copy were administered anti-malarial treatment.
Cross-sectional surveys were performed in the popula-
tion at the start of the long rainy season in 1986–1988,
1993–1999 and 2010. A subset of children aged ten to
19 years was sampled in January 2003 [11]. The cross-
sectional surveys consisted of blood sampling and a gen-
eral health assessment, including an axillary temperature
and auscultation of heart and lungs. A spleen examination
was performed in children and enlarged spleens were
graded according to Hackett’s score [23]. Finger prick
blood was collected for thick and thin films, Hemocue®
blood haemoglobin testing (Ängelholm, Sweden), and op-
tional HIV testing. Venous blood was collected in 4 ml
EDTA tubes (for small children finger pricks in capillary
tubes) and stored frozen as plasma and packed cells.
Detection of malaria parasites by microscopy
Thick and thin films were stained with Giemsa and ana-
lysed by conventional light microscopy. Parasite dens-
ities were estimated per microlitre (μl) of blood and
enumerated against the number of leukocytes assuming
8,000 leukocytes/μl. Blood films were considered nega-
tive if no parasites were detected in 100 microscopic
fields of the thick smear.
Detection of Plasmodium falciparum parasites by PCR
Parasite prevalence was assessed by PCR at the cross-
sectional surveys 1994, 1995, 1999, and 2010 when most
complete surveys across ages were performed. DNA was
purified from frozen packed cells by Qiagen blood mini
kit (Qiagen) (1994, 1995), phenol-chloroform extraction
(1999), and using an automated Qiagen BioRobot® M48
(2010). Real-time PCR for detection of Plasmodium spe-
cies was performed by a multiplex probe-based method
[24] using the ABI TaqMan 7500, with a cut-off of 40 cy-
cles to define positive samples. Genotyping of the P. fal-
ciparum msp2 gene was performed by nested PCR using
fluorescently labelled primers targeting the two allelic
types of msp2 in separate nested reactions, fragment siz-
ing by capillary electrophoresis in a DNA sequencer
(Applied Biosystems), and data analysis by GeneMapper
software [25]. Data on msp1 block 2 genotyping PCR
from 2003 was available from a previous study [11]. The
genotyping results are included here only with regard to
detection of P. falciparum.
Data analysis
Data analysis was performed using GraphPad Prism 5.0
(GraphPad Software Inc, USA) and Stata 13.0 (Stata-
Corp, USA). The data from 1985–1988 were retrieved
from summarized data [3,4]. Parasite prevalence includes
data from microscopy, msp2-PCR and real-time PCR.
Missing prevalence data for msp2-PCR in 1986 and
1993, as well as for microscopy in 2010 (due to staining
artefacts after storage), were estimated using the preva-
lence estimation tool developed by Okell et al., validated
for nested PCR data from all age cross-sectional surveys
[26]. Agreement between methods was evaluated with
the kappa statistic, using the Landis and Koch classifica-
tion. Generalized estimating equation (GEE) regression
models were used to account for statistical dependency
of repeated observations when estimating the association
between survey year and parasite prevalence, prevalence
of sub-microscopic infections, and incidence of malaria.
Complete population censuses were not performed; an-
nual malaria incidence was therefore estimated among
the individuals participating in the respective surveys.
GEE logistic and negative binomial regression models
were used to analyse binary (parasite prevalence), and
count (malaria incidence) outcome variables. For each
outcome, association with survey year was evaluated by
univariate and multivariate models, adjusting for the ef-
fect of potential confounders and/or interactions (i.e.,
age, sex and fever and/or clinical episode of malaria at
the time of survey. Anaemia was classified in four cat-
egories (non-anaemic, mild, moderate, and severe an-
aemia) based on haemoglobin levels according to WHO
age and sex-specific criteria [27]. To evaluate changes in
the overall prevalence of anaemia with time, a binary
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outcome defined as presence or absence of any level of
anaemia was analysed using a univariate GEE logistic re-
gression model. A univariate multinomial logistic regres-
sion model with robust clustering was used to evaluate
changes in the prevalence of the four different levels of
anaemia with time. Results from the multinomial logistic
regression analysis are presented as predicted probabil-
ities with 95% CI.
Ethical considerations
All data and blood samples were collected with informed
consent from each participant and/or their guardians. The
project was approved by the Nyamisati Village Board, the
Ethical Review Board of the National Institute for Medical
Research in Tanzania and the Central Ethical Review
Board in Stockholm, Sweden.
Results
The population of Nyamisati increased from 451 indi-
viduals in 1985 to 1,553 individuals in 1999, as re-
corded by the research team. By 2012, 2,350 individuals
lived in the village according to the National Bureau of
Statistics in Tanzania [28]. The demographics of the in-
dividuals participating in the respective surveys are out-
lined in Table 1.
Parasite prevalence by microscopy and PCR
The overall parasite prevalence by microscopy was
68.7% (95% CI 64.5-72.7%) in 1986–1988, 46.3% (95% CI
42.0-50.5%) in 1993, 38.9% (95% CI 35.5-42.4%) in 1994,
and 26.7% (95% CI 23.8-29.7%) in 1999 (Figure 2).
Species typing by microscopy defined ≥95% of parasite
positive samples as P. falciparum in all surveys. In 2010,
the microscopy prevalence was estimated at 4.8% (95%
credible interval of prediction 3.6-6.3%) from the corre-
sponding msp2-PCR data (according to [26]).
Both PCR methods consistently detected more P. falcip-
arum-positive individuals than microscopy. The agreement
between the real-time PCR and msp2 PCR positivity
was 80% whereas it was 57.4% with microscopy
(Additional file 3). Real-time PCR detected higher
parasite prevalence than msp2-PCR in all years, al-
though the difference was less pronounced in 2010
(Figures 2, 3 and 4). The msp2-PCR prevalence in
1986, as estimated from microscopy prevalence in all
ages by the method of Okell et al. [26], was 83.7%
(95% credibility interval of prediction 79.8-87.0%). The
msp2-PCR prevalence decreased in parallel with mi-
croscopy during the 1990s (1994 58.7%, 95% CI 54.7-
62.2%; 1999 44.8%, 95% CI 41.5-48.2%), whereas real-time
PCR positivity remained at similar levels (1994 69.4%, 95%
CI 65.5-73.1%; 1999 64.8%, 95% CI 61.1-68.4%). In 2010,
real-time PCR prevalence was 17.8% (95% CI 15.1-20.7%)
and msp2-PCR 16.3% (95% CI 13.7-19.1%) (Figure 2).
Asymptomatic parasite prevalence
The proportion of individuals who were febrile or had
history of fever at the time of the cross-sectional survey
varied over the years, being lowest in 1993 (1.1%) and
highest in 1999 (17.0%) (Table 1). The asymptomatic
parasite prevalence was lower than the overall preva-
lence in all surveys, with the largest difference among
children aged 0–16 years in 1999 (Figure 4B). Among
asymptomatic individuals, the odds of an infection be-
ing sub-microscopic increased significantly from 1994
to 1999 (GEE logistic regression age adjusted OR 1.73,
95% CI 1.20-2.49%).
Parasite prevalence by age
In two to nine years old children, the age group conven-
tionally used to estimate malaria endemicity [29], the
parasite prevalence by microscopy was 90% in 1985,
75.2% in 1993, 60.6% in 1994, and 49.0% in 1999
(Figure 3). The prevalence by real-time PCR in this age
group was 78.2% in 1994, 77.2% in 1999 and 12.8% in
2010 (Figure 3).
The peak parasite prevalence by microscopy gradually
shifted to older children. In 1994–1999, the peak preva-
lence was seen in children aged five to eight years by
Table 1 Characteristics of the study population at the respective cross-sectional surveys
1986 1993 1994 1995 1996 1997 1998 1999 2003 2010
Populationa, n 500 1,125 1,295 1,396 1,458 1,424 1,507 1,553 n/a n/a
Cross-sectional survey, n 470 555 792 712 326 337 509 889 105 808
Female, n (%) 239 (51.1) 300 (54.1) 448 (56.6) 403 (56.6) 205 (62.9) 187 (55.5) 276 (54.2) 476 (53.5) 42 (40.0) 407 (50.4)
Age, y median (range) 15 (0–90) 15 (0–83) 14 (0–84) 14 (0–84) 31 (1–86) 22 (1–82) 24 (2–78) 17 (1–84) 13 (10–19) 15 (1–82)
Children ≤16 y, n (%) 260 (55.3) 296 (53.3) 435 (54.9) 391 (54.9) 38 (11.7) 142 (42.1) 183 (36.0) 438 (49.3) 91 (86.7) 431 (53.3)
Children 2–9 y, n (%) 124 (26.4) 154 (27.7) 233 (29.4) 209 (29.4) 10 (3.1) 29 (8.6) 42 (8.2) 243 (27.3) 0 186 (23.0)
Fever at survey, n (%) nd 6 (1.1) 78 (9.8) 89 (12.5) 28 (8.6) 5 (1.4) 25 (4.9) 152 (17.1) 1 (1.0) 23 (2.9)
Fever at survey, 2–9 y,
n (% of all febrile)
nd 3 (50) 60 (77.9) 58 (65.2) 7 (25) 0 2 (8) 95 (62.5) 0 9 (39.1)
aThe population size is based on the individuals registered in the research database at the respective years.
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microscopy and nine to 12 years by PCR. In 2010, the
peak PCR prevalence had shifted to the 13–16 years
group (Figure 4). The proportion sub-microscopic infec-
tions (negative by microscopy and positive by real-time
PCR) increased with age. For instance, in 1999, 9.0% of
asymptomatic individuals >16 years were parasite posi-
tive by microscopy and 51.3% by real-time PCR. The
GEE logistic regression revealed that the odds of being
parasite positive decreased with survey year in all age
groups, with the most pronounced decrease in five to
eight and nine to 12 years old children by real-time PCR
(both OR 0.79, 95% CI 0.76-0.83%) (Table 2). In a subset
of asymptomatic children in 2003, the parasite preva-
lence by microscopy was 3.1 and 13.6% in the ten to 12
and 13–16 years old children, respectively, and 46.9 and
46.6% by msp1-PCR [11].
Spleen rates
Enlarged spleens were recorded in >75% of two to nine
years old children in 1985, 62% in 1986 and 42% in
1988 [3]. In 1993, spleen rate had decreased to 34.1%
(95% CI 26.8-42.2%). During the following years, en-
larged spleens were only sporadically recorded; and in
2010, 1.1% (95% CI 0.1-3.8%) of two to nine years old
children had palpable spleens (Figure 3).
Anaemia
According to the GEE logistic regression analysis, the pro-
portion of individuals with any level of anaemia decreased
significantly over time, and compared to 1994 the odds of
anaemia was lower in 1999 (OR 0.61, 95% CI 0.47-0.79%)
and further reduced in 2010 (OR 0.32, 95% CI 0.24-
0.41%). Multinomial logistic regression analysis showed
Figure 2 Parasite prevalence in Nyamisati 1985–2010 including all ages, by microscopy and two PCR methods (msp2 genotyping PCR
and real-time species-specific PCR). The parasite prevalence by msp2-PCR for 1986 and 1993 as well as microscopy for 2010 were estimated
from slide and msp2-PCR data, respectively, using the prevalence estimation tool developed by Okell et al. [26] (as indicated by *).
Figure 3 Parasite prevalence and spleen rates in children aged two to nine years in repeated cross-sectional surveys in 1985–2010.
Parasite prevalence was assessed by microscopy, real-time PCR, and msp2-PCR. ITNs were distributed in October 1993-April 1994 (n = 300) and in
1999 after the survey (n = 900); LLINs were distributed after the survey 2010 (n = 1,000) (as indicated by arrows). The data from 1986–1988 are
available only as published data, spleen rates are available for individual years, whereas parasite prevalence by microscopy is only available as
pooled data.
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that the prevalence of severe and moderate anaemia de-
creased significantly from 41.4% (95% CI 36.4-46.5%) and
29.6% (95% CI 24.9-34.3%) in 1994 to 33.3% (95% CI 30.2-
36.4%) and 24.8% (95% CI 22.0-27.7%) in 1999 and further
to 27.6 (95% CI 24.5-30.7%) and 13.1% (95% CI 10.7-
15.4%) in 2010, respectively. Prevalence of mild anaemia
remained stable throughout the period at 10.2% (95% CI
7.1-13.3%), 11.9% (95% CI 9.7-14.0%) and 11.9% (95% CI
9.7-14.2%) in 1994, 1999 and 2010, respectively (Figure 5).
Malaria morbidity and mortality
Malaria episodes were diagnosed year round with some
seasonal fluctuations, largely following rainfalls (Figure 6A).
Data on malaria incidence was available from 1986–88 and
1993–1999. Since a systematic demographic surveillance of
the village was not performed, the exact size of the popula-
tion is unknown. Therefore, estimates of malaria incidence
were restricted to the individuals that participated in the
survey and known to be in the village during the period of
surveillance. Malaria incidence was highest among the
youngest children and decreased with increasing age in
all years of surveillance (Figure 6B, Additional file 4).
The incidence of malaria was similar within the re-
spective age groups in 1986–1988 and 1993–1995, with
an increase in the late 1990s. In 1999, a large portion of
episodes coincided with the cross-sectional survey
(Figure 6A).
Parasite densities >250,000 p/μl were detected in 1.7%
of 515 febrile malaria episodes 1986–88 [3] and 0.6% of
the 2,848 episodes in 1993–1999. Parasite densities in
clinical malaria episodes varied between the years and
increased from 1994 until 1998 (Figure 6C).
Severe anaemia was diagnosed in 1% of clinical mal-
aria episodes in 1986–88 and 0.4% in 1993–1999. Sei-
zures were reported in febrile children but there were
no cases of unarousable coma. Other laboratory-based
WHO criteria for severe malaria were not available. No
deaths at the time of acute malaria were recorded when
the research team lived in the village (1985–1991,
1993–2000).
Discussion
The Nyamisati Malaria Research Project provides longi-
tudinal data on the epidemiology of malaria in a rural
African village. A substantial, yet gradual, decline from
holo- to hypo-endemicity was observed over 25 years,
as reflected by changes in parasite prevalence from 90
to <10% in two to nine years old children. Spleen rates
decreased before changes in parasite prevalence were
observed. Parasite prevalence by PCR, especially real-
time PCR, remained high during the 1990s, and then
revealed a substantial decrease by 2010.
This study adds to a number of reports of changing mal-
aria epidemiology, giving hope for elimination of malaria
Figure 4 Age patterns of parasite prevalence by microscopy, real-time PCR, and msp2-PCR A) overall and B) in asymptomatic
individuals in 1994, 1999 and 2010.
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in some settings [1,19-21]. The long observation time con-
tributes with historical data on malaria before the more
recently introduced control interventions. Interestingly,
very similar declines in malaria over the same time period
have recently been reported from Muheza, Northern
Tanzania [30] and Dielmo, Senegal [31].
The changes in transmission in Nyamisati were detected
by different methods over time which demonstrates the
advantage of using several metrics, i.e., spleen rates, mi-
croscopy and PCR in longitudinal surveillance. Molecular
methods, especially PCR, have become increasingly
used in epidemiological studies, and often reveal a large
proportion of sub-microscopic infections [26]. The advan-
tages and disadvantages of different methods to measure
malaria transmission are well described in recent reviews
(spleen rate not included) [32,33].
The first malariometric index to capture changes in
the burden of malaria was spleen rate, which decreased
down to nil while parasite prevalence by microscopy in
the same two to nine age group remained above 75%.
Spleen rate (the proportion of children with enlarged
spleens) was once the standard method to define mal-
aria endemicity [29], but is no longer included in the
Table 2 Linear time-trend of odds of Plasmodium falciparum infection assessed by generalized estimating equation
logistic regression models
All Asymptomatica
OR (95% CI) OR (95% CI)
Microscopyb msp2-PCRc Real-time PCRd Microscopyb msp2-PCRc Real-time PCRd
Yeare
Age group
0-4 0.86 (0.83, 0.88) 0.90 (0.88, 0.91) 0.87 (0.85, 0.89) 0.73 (0.70, 0.77) 0.87 (0.86, 0.89) 0.85 (0.83, 0.86)
5-8 0.86 (0.83, 0.88) 0.80 (0.76, 0.85) 0.79 (0.76, 0.83) 0.73 (0.70, 0.77) 0.87 (0.86, 0.89) 0.85 (0.83, 0.86)
9-12 0.86 (0.83, 0.88) 0.82 (0.79, 0.86) 0.79 (0.76, 0.82) 0.73 (0.70, 0.77) 0.87 (0.86, 0.89) 0.85 (0.83, 0.86)
13-16 0.86 (0.83, 0.88) 0.90 (0.88, 0.91) 0.87 (0.85, 0.89) 0.73 (0.70, 0.77) 0.87 (0.86, 0.89) 0.85 (0.83, 0.86)
>16 0.86 (0.83, 0.88) 0.90 (0.88, 0.91) 0.87 (0.85, 0.89) 0.83 (0.78, 0.89) 0.87 (0.86, 0.89) 0.85 (0.83, 0.86)
Age groupf
0-4 1 (−) 1 (−) 1 (−) 1 (−) 1 (−) 1 (−)
5-8 1.92 (1.46, 2.51) 3.20 (1.93, 5.31) 3.27 (1.97, 5.41) 2.60 (1.87, 3.61) 2.76 (1.70, 4.48) 2.39 (1.51, 3.77)
9-12 1.04 (0.79, 1.37) 3.87 (2.31, 6.48) 6.06 (3.53, 10.4) 1.86 (1.34, 2.59) 4.28 (2.67, 6.86) 4.73 (3.03, 7.40)
13-16 0.84 (0.63, 1.14) 2.14 (1.45, 3.16) 2.70 (1.82, 4.01) 1.65 (1.16, 2.36) 5.28 (3.26, 8.57) 4.92 (3.11, 7.77)
>16 0.23 (0.18, 0.30) 0.71 (0.52, 0.98) 1.04 (0.75, 1.45) 0.34 (0.25, 0.47) 1.56 (1.03, 2.36) 1.84 (1.25, 2.72)
aAsymptomatic defined as absence of fever, history of fever or treatment at survey.
bBased on microscopy data from 1993–1999.
cBased on real-time PCR data from 1994–2010.
dBased on msp2-PCR data from 1994–2010.
eAge-group specific effect of time (in years) on parasite prevalence.
fEffect of age on parasite prevalence at baseline.
In the GEE logistic regression analysis year of survey was treated as a continuous variable and age group as a categorical variable in five categories (ages: 0–4,
5–8, 9–12, 13–16, and >16 years). Due to significant interaction between year of survey and age group, effect of time on prevalence is presented as age group
specific OR.
The odds of both overall and asymptomatic P. falciparum infection decreased with time and were most pronounced in asymptomatic individuals by microscopy.
Abbreviations: OR odds ratio, CI confidence interval, msp2 merozoite surface protein 2 gene.
Figure 5 Proportion of Nyamisati population with mild,
moderate and severe anaemia at cross-sectional surveys,
classified according to age and sex-specific WHO criteria [27].
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Figure 6 Clinical episodes of malaria. A) Number of clinical episodes of malaria diagnosed each month in 1993–1999 at the Nyamisati Health
Clinic (bars) and rainfall patterns (solid line) averaged from data from the nearest meteorological stations of Utete, Kingupira, Kilwa Masoko, and
Dar es Salaam International Airport, provided by the Tanzania Meteorological Agency; B) Incidence rate of clinical malaria by age over three
observation periods 1986–1988, 1993–1995, and 1998–1999 (no data available 2010); C) Parasite densities in febrile malaria episodes over years.
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WHO guidelines for malaria surveillance, being replaced
by assessments of parasite prevalence [34]. Although
spleen size is unspecific for malaria on the individual level,
spleen rates may still be useful as a screening tool on the
population level. The data suggest that assessment of
spleen size in combination with microscopy can detect
early changes in areas of most intense transmission, e.g.
after implementation of new control interventions. This is
supported by similar decreases in spleen rates, down to
nil, observed as transmission declined in the longitudinal
studies in north-eastern Tanzania [30] and Senegal [31].
Microscopy showed a gradual decrease in parasite
prevalence over time. Among asymptomatic individuals,
microscopy detected an even more rapid decrease in
parasite prevalence, indicating the value of defining the
clinical status of individuals in cross-sectional epidemio-
logical surveys.
The use of PCR was found most informative when
transmission had decreased to a moderate or low level,
as suggested in previous reviews [32,33]. PCR is well rec-
ognized to be a more sensitive method for parasite de-
tection compared to microscopy, often revealing a large
proportion of sub-microscopic infections in epidemio-
logical studies [26]. This was also apparent here, espe-
cially as malaria declined in the 1990s. Furthermore, the
choice of PCR method affects the interpretation of re-
sults on parasite prevalence. Including data from msp2-
PCR allowed estimates of missing microscopy data ac-
cording to the method by Okell et al., which is based on
nested PCR data [26]. Real-time PCR had higher sensi-
tivity than msp2-PCR, likely due to differences in tar-
geted genes (the multi-copy small subunit ribosomal
RNA gene [35] versus the single copy msp2 gene [36]).
Real-time PCR prevalence remained high during the
1990s and would not alone have revealed the changes in
transmission detected by the other methods. The high
number of sub-microscopic infections detected by real-
time PCR likely contributed to ongoing transmission in
this setting [37], demonstrating the importance of using
sensitive molecular methods to monitor epidemiology at
stages of decreasing transmission.
The age patterns of parasite prevalence changed over the
study period. The age group with the highest prevalence
gradually shifted to older children, suggesting reduced im-
munity as a result of lower exposure as previously de-
scribed [38,39]. During the 1990s, increasing incidence of
clinical malaria was observed which also might indicate a
somewhat reduced immunity in the community as parasite
prevalence declined during the 1990s. Moreover, a large
number of symptomatic infections coincided with the
cross-sectional survey in 1999, possibly reflecting changes
to a more seasonal pattern of malaria transmission. The in-
creasing incidence might, however, also reflect changes in
drug susceptibility with increasing SP resistance. A similar
trend was reported in Senegal before incidence eventually
decreased in 2000s [31].
Cases of severe and fatal malaria were remarkably rare
in the village. The continuous presence of a physician
could have contributed to the paucity of severe malaria.
However, malaria mortality was also low at the referral
hospital in Mchukwi [40] and absence of malaria-specific
mortality has been described in other settings of high
transmission [31,41]. Changes in transmission might have
altered incidence and severity of malaria in the village as a
result of lower exposure to parasites. Malaria case data
was unfortunately not available after 2000. Nonetheless,
the low parasite prevalence in 2010 reflects a level of un-
stable transmission with potential increased risk of malaria
and severe malaria in all age groups [20,33].
The proportion of individuals with severe and moder-
ate anaemia declined over time. Increasing haemoglobin
levels were also reported in the Pwani region in the
Tanzania Demographic and Health Survey in 2010 [42].
There was no iron or vitamin supplementation pro-
grammes in Nyamisati. The decrease in parasite burden
likely contributed to these changes since anaemia is an
important consequence of symptomatic and asymptom-
atic P. falciparum infections [43].
Declining transmission has been associated with
introduction of one or several interventions, such as
ITN/LLIN and artemisinin-based combination therapy
(ACT) [19,31]. However, in some areas, such as in Uganda,
malaria morbidity has increased despite scaling-up of con-
trol interventions [44]. The distribution of ITN in 1993–
1994 and 1999 might partly explain the decreasing trends
in parasite prevalence in Nyamisati, whereas ACT was not
available until 2009 and access was low in the Rufiji district
[45]. Nonetheless, decline in parasite burden as reflected
by spleen rates and microscopy prevalence was observed
already in the 1980s, i.e. before any of these control inter-
ventions were implemented. Also in other settings, such as
The Gambia [21] and Kenya [20], declining transmission
has been observed before the expansion of malaria control.
Interestingly, the declines in parasite prevalence over
two decades in north-eastern Tanzania [30] and Senegal
[31] are similar to the pattern observed in Nyamisati,
despite differences regarding types and timing of inter-
ventions. In those areas, the Anopheles vector popula-
tions decreased markedly [46], along with changing
vector species distribution [47] and entomological in-
oculation rates [31]. Entomological data are unfortu-
nately not available in Nyamisati. In the Rufiji River
Basin, the predominant species within the malaria-
transmitting Anopheles gambiae complex were Anopheles
gambiae s.s, Anopheles arabiensis and Anopheles merus in
2003–2004 [48]. Changes in rainfall or temperature might
have impacted on the vector [49], nonetheless no apparent
changing trends in these observations were registered in
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nearby weather stations in coastal Tanzania during this
25-year period (Additional file 1).
The presence of a research team closely monitoring
malaria with prompt and efficacious treatment is likely
to have contributed to reducing parasite prevalence in
Nyamisati and other closely monitored communities
[30,31]. Already one year after the medical services were
established in Nyamisati, mothers reported that their
children’s health status had improved [3]. Nonetheless,
the parasite prevalence continued to decrease after the
research team left the village in 2000, suggesting that
other factors contributed to the declining transmission.
Also at a nearby Rufiji Demographic Surveillance Site
(DSS), parasite prevalence decreased from 23 to 14% by
microscopy during 2001–2006 [50]. Although the lack of
data in Nyamisati between 2000 and 2010 is a limitation
of the study, it is also interesting that transmission de-
clined despite the research team not being present. A
factor that could have contributed to the decline is im-
proved socio-economic status [51]. The village was ini-
tially very remote and isolated. Transportation improved
over the years with tarmac roads and daily busses that
began coming to Nyamisati in 2004, as it became the
main port for ferries to Mafia Island. Nevertheless, hous-
ing conditions in the village remained similar during the
study period.
The study is limited by data not being equally available
for all variables at all time points. Cross-sectional surveys
only provide a snapshot of the malaria transmission and
incidence data available for only part of the study period.
Nonetheless, the major strength of the study is that the
continuous malaria surveillance and cross-surveys were
performed at the same time of the year (at the beginning
of the rainy season) by the same physician and research
team (including microscopy as well as clinical and spleen
assessments), using the same sample collection tubes and
processing, thus providing a unique consistency and com-
parability over this extended period of time. Moreover,
only the survey years with complete data and samples
available throughout the different ages were included in
the analyses. Another limitation might be that DNA ex-
tractions were performed by different methods for the dif-
ferent years, which potentially could affect the sensitivity
of detection. However, the PCR analyses were recently
performed in a highly standardized fashion by the same
individual. Moreover, the samples collected 1994 and 2010
were extracted by similar commercial kits (manual and
automated, respectively) and can thus be considered
highly comparable.
Conclusion
The study demonstrates declining malaria transmission
in this East African village over 25 years. Moreover it
demonstrates the value of using different methods to
monitor malaria transmission. Spleen rates and micros-
copy detect early changes when transmission is still in-
tense. Conversely, PCR, especially real-time PCR, does
not detect initial changes in transmission, but robustly and
sensitively reveals a large proportion of sub-microscopic
infections as transmission declines in a population.
The gradually declining transmission appears to have
started already in the 1980s, with the arrival of the re-
search team in 1985, and continued gradually after that.
From the present data it is not possible to determine
how much the interventions with ITNs contributed to
the decline, partly because of the lack of data between
2000 and 2010. Further studies, using sero-epidemiological
tools might contribute to the understanding of patterns
and timing of transmission changes in periods when para-
site prevalence data is missing. The historical data on mal-
aria within this longitudinally, closely monitored rural
village contributes to the understanding of changing epi-
demiology in sub-Saharan Africa over the last decades.
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